Home > Qtrly Results > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Quarterly Results Analysis [Jun2025]

NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Quarterly Results

Consolidated Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
Audited
Sep2024
Audited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
Audited
Revenues ₹284 Cr ₹52 Cr ₹37 Cr ₹32 Cr ₹244 Cr ₹43 Cr ₹32 Cr ₹23 Cr
Expenses ₹245 Cr ₹52 Cr ₹29 Cr ₹27 Cr ₹207 Cr ₹39 Cr ₹26 Cr ₹18 Cr
Operating Income ₹38 Cr ₹0 Cr ₹8 Cr ₹5 Cr ₹37 Cr ₹4 Cr ₹6 Cr ₹5 Cr
Other Income ₹2 Cr ₹4 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Interest ₹3 Cr ₹1 Cr ₹4 Cr ₹3 Cr ₹2 Cr ₹1 Cr ₹3 Cr ₹2 Cr
Depreciation ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Profit Before Tax ₹36 Cr ₹2 Cr ₹4 Cr ₹1 Cr ₹34 Cr ₹2 Cr ₹5 Cr ₹2 Cr
Profit After Tax ₹35 Cr ₹1 Cr ₹3 Cr ₹1 Cr ₹33 Cr ₹2 Cr ₹4 Cr ₹2 Cr
EPS ₹19.62 ₹0.78 ₹1.39 ₹0.59 ₹17.55 ₹1.38 ₹2.01 ₹0.80
Industry Peers & Returns1W1M1Y
NATH BIOGENES (INDIA) -4.1% -23% -24%
BOMBAY BURMAH TRADING CORPORATION -3% -6.8% -12.5%
KAVERI SEED COMPANY -2.1% -8.1% 4.2%
VENKYS (INDIA) 0.5% -5.7% -32%
BOMBAY SUPER HYBRID SEEDS -2.3% -4.4% -29.6%
INDO US BIOTECH -3.4% 8% -21.2%
MANGALAM GLOBAL ENTERPRISE -3.9% -2.2% NA
HARRISONS MALAYALAM 4.7% 0.8% -7%
TIERRA AGROTECH 6.7% 2.4% -35.7%

NATH BIOGENES (INDIA) Quarterly Revenues

Revenues
Q-o-Q

445.91 %

Y-o-Y

16.33 %

Quarters Revenues % Change
Jun2025 ₹284 Cr
445.91
Mar2025 ₹52 Cr
40.94
Dec2024 ₹37 Cr
14.54
Sep2024 ₹32 Cr
-86.80
Jun2024 ₹244 Cr
466.65
Mar2024 ₹43 Cr
35.60
Dec2023 ₹32 Cr
40.63
Sep2023 ₹23 Cr -

NATH BIOGENES (INDIA) Quarterly Operating Profit

Operating Profit
Q-o-Q

9,169.73 %

Y-o-Y

4.79 %

Quarters Operating Profit % Change
Jun2025 ₹38 Cr
9,169.73
Mar2025 ₹0 Cr
-94.86
Dec2024 ₹8 Cr
67.01
Sep2024 ₹5 Cr
-86.83
Jun2024 ₹37 Cr
830.12
Mar2024 ₹4 Cr
-30.43
Dec2023 ₹6 Cr
13.35
Sep2023 ₹5 Cr -
Operating Margins
Q-o-Q

1,607.59 %

Y-o-Y

-9.95 %

Quarters Operating Margin% % Change
Jun2025 13.49%
1,607.59
Mar2025 0.79%
-96.38
Dec2024 21.8%
45.82
Sep2024 14.95%
-0.20
Jun2024 14.98%
64.07
Mar2024 9.13%
-48.68
Dec2023 17.79%
-19.39
Sep2023 22.07% -

NATH BIOGENES (INDIA) Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

3,646.49 %

Y-o-Y

5.59 %

Quarters Profit After Tax % Change
Jun2025 ₹35 Cr
3,646.49
Mar2025 ₹1 Cr
-64.54
Dec2024 ₹3 Cr
137.97
Sep2024 ₹1 Cr
-96.66
Jun2024 ₹33 Cr
1,897.25
Mar2024 ₹2 Cr
-56.27
Dec2023 ₹4 Cr
154.43
Sep2023 ₹2 Cr -
PAT Margins
Q-o-Q

585.64 %

Y-o-Y

-9.28 %

Quarters PAT Margin(%) % Change
Jun2025 12.41 %
585.64
Mar2025 1.81 %
-74.83
Dec2024 7.19 %
107.80
Sep2024 3.46 %
-74.71
Jun2024 13.68 %
252.58
Mar2024 3.88 %
-67.75
Dec2023 12.03 %
80.90
Sep2023 6.65 % -

NATH BIOGENES (INDIA) Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

2,415.38 %

Y-o-Y

11.79 %

Quarters EPS % Change
Jun2025 ₹19.62
2,415.38
Mar2025 ₹0.78
-43.88
Dec2024 ₹1.39
135.59
Sep2024 ₹0.59
-96.64
Jun2024 ₹17.55
1,171.74
Mar2024 ₹1.38
-31.34
Dec2023 ₹2.01
151.25
Sep2023 ₹0.8 -

You may also like the below Video Courses